The IL2RG R328X nonsense mutation allows partial STAT5 phosphorylation and defines a critical region involved in leaky-SCID phenotype.
In addition to their detection in typical X-linked severe combined immunodeficiency, hypomorphic mutations in the IL-2 receptor common gamma chain gene (IL2RG) have been described in patients with atypical clinical and immunological phenotypes. In this leaky clinical phenotype, the diagnosis is often delayed, limiting prompt therapy in these patients. Here, we report the biochemical and functional characterization of a nonsense mutation in exon 8 (p.R328X) of IL2RG in 2 siblings: a 4-year-old boy with lethal Epstein Barr virus-related lymphoma and his asymptomatic 8-month-old brother with a Tlow B+ NK+ immunophenotype, dysgammaglobulinemia, abnormal lymphocyte proliferation, and reduced levels of T cell receptor excision circles. After confirming normal IL2RG expression (CD132) on T lymphocytes, STAT5 phosphorylation was examined to evaluate the functionality of the common gamma chain (γc ), which showed partially preserved function. Co-immunoprecipitation experiments were performed to assess the interaction capacity of the R328X mutant with JAK3, concluding that R328X impairs JAK3 binding to γc . Here, we describe how the R328X mutation in IL2RG may allow partial phosphorylation of STAT5 through a JAK3-independent pathway. We identified a region of 3 amino acids in the γc intracellular domain that may be critical for receptor stabilization and allow this alternative signaling. Identification of the functional consequences of pathogenic IL2RG variants at the cellular level is important to enable better understanding of partial defects leading to leaky phenotypes.